99 related articles for article (PubMed ID: 23385443)
21. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.
Jensen UB; Sunde L; Timshel S; Halvarsson B; Nissen A; Bernstein I; Nilbert M
Breast Cancer Res Treat; 2010 Apr; 120(3):777-82. PubMed ID: 19575290
[TBL] [Abstract][Full Text] [Related]
22. [Familial non-polyposis colorectal carcinoma (Lynch syndrome) in Germany - analysis of information, advisory service and family screening].
Schneider R; Rümmele P; Dechant S; Hofstädter F; Lorenz W; Fürst A
Dtsch Med Wochenschr; 2011 Jan; 136(1-2):17-22. PubMed ID: 21181610
[TBL] [Abstract][Full Text] [Related]
23. Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma.
Westenend PJ; Dinjens WN
Hum Pathol; 2018 Jun; 76():169. PubMed ID: 29634980
[No Abstract] [Full Text] [Related]
24. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
25. Lynch syndrome: a pediatric perspective.
Huang SC; Durno CA; Erdman SH
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):144-52. PubMed ID: 24051481
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G;
Fam Cancer; 2020 Oct; 19(4):337-346. PubMed ID: 32385704
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.
Hu P; Lee CW; Xu JP; Simien C; Fan CL; Tam M; Ramagli L; Brown BW; Lynch P; Frazier ML; Siciliano MJ; Coolbaugh-Murphy M
Ann Clin Lab Sci; 2011; 41(4):321-30. PubMed ID: 22166501
[TBL] [Abstract][Full Text] [Related]
28. Familial endometrial cancer in female carriers of MSH6 germline mutations.
Wijnen J; de Leeuw W; Vasen H; van der Klift H; Møller P; Stormorken A; Meijers-Heijboer H; Lindhout D; Menko F; Vossen S; Möslein G; Tops C; Bröcker-Vriends A; Wu Y; Hofstra R; Sijmons R; Cornelisse C; Morreau H; Fodde R
Nat Genet; 1999 Oct; 23(2):142-4. PubMed ID: 10508506
[No Abstract] [Full Text] [Related]
29. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
30. Origin of MLH1, MSH2, MSH6 and PMS2 mutations can help inform long-term care strategies for patients with colorectal and endometrial cancer.
Hickmott JW
Clin Genet; 2015 Jun; 87(6):534-5. PubMed ID: 25761822
[No Abstract] [Full Text] [Related]
31. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
[TBL] [Abstract][Full Text] [Related]
33. [Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis].
Ríos A; Rodríguez JM; Carbonel P; Parrilla P
Med Clin (Barc); 2015 Feb; 144(4):185-6. PubMed ID: 25458510
[No Abstract] [Full Text] [Related]
34. Simplified identification of Lynch syndrome: a prospective, multicenter study.
Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
[TBL] [Abstract][Full Text] [Related]
35. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
[TBL] [Abstract][Full Text] [Related]
36. StatBite: Lynch syndrome increases the risk of various cancers.
J Natl Cancer Inst; 2010 Sep; 102(18):1383. PubMed ID: 20826736
[No Abstract] [Full Text] [Related]
37. Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated.
Renehan AG
Gut; 2012 May; 61(5):783; author reply 783-4. PubMed ID: 21873468
[No Abstract] [Full Text] [Related]
38. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
39. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
